Statin drugs that assist in maximizing tolerable doses help adult patients with elevated triglyceride levels who have been diagnosed with cardiovascular disease, diabetes, or who have two or more other cardiovascular risk factors to reduce the risk of myocardial infarction, stroke, coronary artery revascularization, and unstable angina.
Icosapentate Ethyl 96.5% is a high-purity pharmaceutical intermediate derived from eicosapentaenoic acid (EPA). Manufactured via enzymatic esterification and fractional crystallization, it serves as the active moiety for triglyceride-lowering therapies. The molecular formula is C24H36O2, with CAS No. 107830-27-1.
Strictly controlled substance; requires storage below -20°C under inert atmosphere to prevent oxidation. Clinical use mandates monitoring for bleeding risks and liver enzyme elevation. Handling requires PPE due to potential irritant properties.